
September 25, 2015 Medical Communications, Research and Development Entresto, Novartis, eams, heart failure

September 25, 2015 Research and Development MSD, Merck

September 25, 2015 Medical Communications, Research and Development COPD, lung cancer, smkoing

September 23, 2015 Research and Development Boehringer Ingelheim, COPD

September 23, 2015 Research and Development HIV, Triumeq, ViiV, virology
September 23, 2015 Research and Development R&D, drug development, market access, productivity

September 22, 2015 Manufacturing and Production, Research and Development GSK, Scotland, manufacturing

September 21, 2015 Research and Development, Sales and Marketing Esbriet, European Respiratory Congress, Roche, idiopathic pulmonary fibrosis, pirfenidone

September 21, 2015 Research and Development, Sales and Marketing Boehringer Ingelheim, EASD, Eli Lilly, cardiovascular risk, empagliflozin, jardiance, mortality risk, type 2 diabetes
September 21, 2015 Research and Development, Sales and Marketing Biocair
September 18, 2015 Research and Development, Sales and Marketing BMS, Breakthrough Therapy Designation, Bristol-Myers Squibb, FDA, Kidney cancer, immuno-oncology, immunotherapy, nivolumab, opdivo, renal cell carcinoma

September 18, 2015 Medical Communications, Research and Development Global Innovation Index, World Intellectual Property Organisation, innovation, intellectual property, patents, wipo

September 17, 2015 Research and Development AstraZeneca, Azactam, BARDA, Department of Health and Human Services, HHHS, avibactam, aztreonam

September 16, 2015 Research and Development, Sales and Marketing Amgen, Cancer, Denzime, Xencor, cardiovascular disease, high cholesterol, inflammation

September 16, 2015 Research and Development Lantus, LixiLan, Lixisenatide, Lxyumia, Sanofi, diabetes, insulin glargine, metformin, type 2 diabetes